United States · FDA National Drug Code directory
Jardiance
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71610-177_422a084f-5495-2335-e063-6394a90a8736
- Product NDC
- 71610-177
- Form
- TABLET, FILM COATED
- Composition / generic term
- Empagliflozin
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 20140801
- Source listing expiry
- 20261231
Source-listed ingredients
- EMPAGLIFLOZIN — 25 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 9000 TABLET, FILM COATED in 1 BOTTLE (71610-177-09) · 71610-177-09
- 15 TABLET, FILM COATED in 1 BOTTLE (71610-177-15) · 71610-177-15
- 1800 TABLET, FILM COATED in 1 BOTTLE (71610-177-42) · 71610-177-42
- 45 TABLET, FILM COATED in 1 BOTTLE (71610-177-45) · 71610-177-45
- 1080 TABLET, FILM COATED in 1 BOTTLE (71610-177-81) · 71610-177-81
- 5040 TABLET, FILM COATED in 1 BOTTLE (71610-177-99) · 71610-177-99
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →